Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Pfizer Hemophilia B Gene Therapy Durveqtix Wins EC Authorization
Sage Therapeutics Cut to Neutral at J.P. Morgan on Pipeline Concerns
Bristol-Myers Squibb Q2 Earnings Preview: Strong Results on the Back of Legacy Portfolio
This Is What Whales Are Betting On Gilead Sciences
Pfizer's Options: A Look at What the Big Money Is Thinking
Notable Earnings Before Friday's Open